{"disease":{"id":"iga-glomerulonephritis","name":"iga glomerulonephritis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03929887","title":"KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT01560052","title":"Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)","phase":"NA","overall_status":"COMPLETED","enrollment_count":503,"lead_sponsor_name":"The George Institute","has_results":false},{"nct_id":"NCT05434325","title":"TESTING -ON Post-Trial ObservatioNal Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":366,"lead_sponsor_name":"The George Institute","has_results":false},{"nct_id":"NCT05797051","title":"Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT03841448","title":"A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Alnylam Pharmaceuticals","has_results":true},{"nct_id":"NCT07389499","title":"A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Grit Biotechnology","has_results":false},{"nct_id":"NCT03453619","title":"Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Apellis Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04663204","title":"A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":12,"lead_sponsor_name":"University of Leicester","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}